Cervical Cancer Essay

What is the Human Papillomavirus? Commonly known as HPV, it is an infection that spreads through sexual contact. There are over one hundred different types of HPV; several types cause genital warts, while other high risk strands can lead to cancer of the cervix, anus, vagina, and penis. Because HPV is often asymptomatic, many people are unaware of their infection status, and thus, their potential for transmitting the virus to a sexual partner. The significance of the Human Papillomavirus is that fifty percent of Americans who are sexually active will contract it within their lives, and at any given point there are twenty million Americans already infected with it (“By the numbers: HPV Vaccine”).

The human papillomavirus (HPV) is a sexually transmitted disease (STD) that is very common throughout the United States and worldwide (World Health Organization (WHO), 2016). There are over 100 different forms of the virus with 13 of these types being capable of causing cancer (WHO, 2016). HPV can lead to the development of serious health problems. Theses health problems are especially an issue for adolescent women due to the highly increasing STD rates among this age group (Kostas-Polston, Johnson-Mallard & Berman, 2012). There is a vaccine for many of the common types of HPV, however, many parents are refusing to vaccinate their daughters for various reasons. With the rising cases of STDs, less birth

Human papillomavirus (HPV) infection is a widespread sexually transmitted infection. Approximately 14 million Americans are infected with HPV each year ("HPV Vaccine for Preteens and Teens,"). HPV also causes several types of cancers, such as vaginal cancer and anal cancer. More than 27,000 women and men are affected by a HPV-related cancer annually ("The Link Between HPV and Cancer,"). The most common HPV cancers for women and men are cervical cancer, and oral cavity and oropharyngeal cancers, respectively. Research has demonstrated that many cancers caused by HPV can be prevented by the HPV vaccine, which is administered in 3 doses over 6 months ("The

I have chosen this paper since one of my goals during the Integrated Practicum was to gain knowledge about cancer prevention and management in the community settings. I believe that this article might increase my understanding about the usage of HPV Vaccines in prevention of various types of cancer.

Almost all cervical carcinomas are caused by Human papillomavirus (HPV). Cervical cancer can be a life-threating disease. However, over recent years the occurrence of cervical cancer has declined as well as the chance of dying from it. A huge contributing factor to this decline is the importance of a regular pap smear. A pap smear can find cervical pre-cancer before it turns into cancer. Recently, a vaccine for HPV, has been on the market, which provides close to a 100% protection against pre-cancer and general warts. HPV and cervical cancer are two disease that are closely related. However, each disease effects not only similar populations, but also different populations, as well as having its own signs and symptoms, detection procedures,

Human Papilloma Virus, more commonly known as HPV, is a sexually transmitted virus. It is spread from skin-to-skin contact with an infected person, typically during sexual encounters. It is the most common sexually transmitted disease in the United States. According to the Immunize Action Coalition, “most sexually active American men and woman will contract at least one type of HPV virus during their lifetime” (A Parent 's Guide to Preteen, 2013, p. 1). To put the numbers in perspective, it infects an estimated seventy-nine million Americans today with approximately fourteen million more people being affected additionally each year (Human

The HPV vaccine has been proven to greatly reduce the chance of contracting HPV-related cervical cancer. There are currently two FDA-approved vaccines released to target the four most common HPV strains. Approximately, 70 percent of cervical cancer and 90 percent of genital warts are associated with these four strains of HPV. The Advisory Committee on Immunization Practices (ACIP) recommends vaccinating young girls and boys ages 11 and 12 years, before becoming sexually active. Additionally, ACIP recommends vaccination of HPV4 for males between ages 13 and 26 years who have not been previously vaccinated or have not accomplished the three-dose series. Public health concerns have led to enacted legislatures by twenty-five states for HPV vaccination mandates for school enrollment. Other states have introduced legislation to fund or educate the public or school adolescents regarding the HPV vaccine (Hanson,

Currently, cervical cancer is highly preventable. Nine out of ten women survive cervical cancer when it is caught and treated early (Texas Cancer). While annual pap smear is an important tool to detect cervical cancer, HPV vaccination in teenagers has been shown to decrease the rates of cervical cancer (Texas Cancer). As the current rate of HPV vaccination remains low, there is pressing need for an innovative solution to increase HPV vaccination among teenagers, especially those in high-risk groups such as Hispanics and African Americans.

Among the 12, 200 new cases of cervical cancer ninety-percent of them are caused or attributed to HPV.

“4,210 deaths have occurred with cervical cancer.”(cancer.net) 12,820 women in the U.S will be diagnosed. If the cancer has spread from the cervix to other parts it’s a five year survival rate is 17 percent. The 5 year survival rate tells you what percent of women live at least 5 years after the cancer is found. The 5 year survival rate for all women with cervical cancer is 68%. For white women, the 5 year survival rate are 69%. For african american women the survival rate is 57%. “More than 15% of cases of cervical cancer are found in women over 65.” “(key statistics)” In the United States, Hispanic women are most likely to get cervical cancer, followed by African Americans, Asians and Pacific Islanders and whites. American Indians and Alaskan natives have the lowest risk of cervical cancer in this country. Cervical cancer rates for women have gone up every year for women and if we don’t find better treatments we won’t get to point of curing this

Previous research on HPV acceptability was focused on identifying at risk population and implementing strategies to promote the benefits of the vaccine. Questions regarding safety concerns and adverse events remain unanswered for the parents there by getting a confident approval from them is a daunting task. This study examines the knowledge, attitudes and practices of parents that mould their decisions to get their children vaccinated.

Human Papilloma Virus (HPV) is a communicable, sexually transmitted disease with high prevalence rates in the general population (CDC, HPV, 2015). Although many people who contract this disease will never develop clinical symptoms, HPV may cause cancer many years later (CDC HPV, 2015). For example, one in every 142 women will develop cervical cancer due to HPV in her lifetime (CDC HPV, 2015). HPV vaccines have been developed and administered in recent years for the prevention of HPV and cervical cancer, but it must be given prior to HPV exposure (CDC HPV, 2015). The HPV vaccine is greater than 90% effective in eradication of the HPV strains that cause cancer (CDC, HPV, 2015). HPV has unique public health implications since it is rare that vaccines can prevent future cancers.

Specific purpose: To persuade my audience why they should give their pre-teen the Human Papilloma Virus (HPV) vaccine.

Although the human papillomavirus (HPV) has been implicated in 90% of cervical cancer cases, HPV infection is transient and usually doesn’t lead to cancer, indicating that oncogenic

Cervical cancer is one of the leading causes of death among women worldwide, it is right behind breast cancer in morbidity rates of all cancers in women (Jalan et al. abstract). According to the scholarly article “Providers’ Beliefs About the Effectiveness of the HPV Vaccine in Preventing Cancer and Their Recommended Age Groups for Vaccination: Findings